MedPath

Lumbar Drainage of Intraventricular Hemorrhage

Not Applicable
Recruiting
Conditions
Intraventricular Hemorrhage
Lumbar Drainage
External Ventricular Drainage
Interventions
Other: External drainage of intraventricular hemorrhage
Registration Number
NCT06510842
Lead Sponsor
University Hospital Heidelberg
Brief Summary

Intracerebral hemorrhage (ICH) is a debilitating and fatal disease, especially when the hemorrhage is also entering the cerebral ventricles leading to acute hydrocephalus. In these cases, patients need a drainage through external ventricular drains (EVD). In the longer term, patients often need a permanent ventriculoperitoneal (VP) shunt to avoid hydrocephalus. Here we hypothesize that the early insertion of a lumbar drainage in addition to the EVD could lead to better functional outcome and avoidance of VP shunting by drainage of the blood which promotes inflammatory and adverse effects in the subarachnoid space. For that we propose a multi-center randomized clinical trial to investigate the hypothesis.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
354
Inclusion Criteria
  • ICH with IVH (with hemorrhage in the 3rd and/or 4rth ventricle) with the need for EVD placement due to acute hydrocephalus
  • Age ≥ 18 y
  • Lumbar drain can be inserted within 72 h after symptom onset or patient last seen well
Exclusion Criteria
  • Premorbid mRS score > 2
  • Pregnancy
  • Life expectancy <6 months
  • Patient/family/caregiver unwilling or unlikely to opt for at least two weeks of aggressive therapy prior to consideration of transition to comfort measures/discontinuation of life support measures.
  • Treating physicians deeming the prognosis as so grave that an aggressive therapy is not warranted.
  • Other clear contraindication for treatment with a lumbar drain

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control armExternal drainage of intraventricular hemorrhageStandard of care consists of drainage of CSF via EVD with or without intraventricular thrombolysis.
Intervention armExternal drainage of intraventricular hemorrhageAdditional insertion of a lumbar drainage.
Primary Outcome Measures
NameTimeMethod
Rate of mRS180 days (+/- 14 days)

The mRS is frequently employed to assess functional outcome of stroke therapy - its ease of use, simplicity of interpretation for clinicians and families, and agreement with other stroke scales are appealing features. The use of fixed dichotomous analysis of ordered categorical outcomes after stroke (mRS 0-3 favorable vs. 4-6 non-favorable outcome) has proved to be valid and reliable for defining outcome in stroke patients in many previous studies.

Secondary Outcome Measures
NameTimeMethod
Amount of CSF drained by external ventricular drainup to 14 days (duration of hospital stay)

in ml

Need for VP shuntat 180 days

operative implantation of VP shunt

Clearance of intraventricular blood (via neuroimaging with CT or MRI)up to 14 days (duration of hospital stay)

Opening of fourth ventricle (y/n)

Bacterial Ventriculitis/Meningitis leading to antibiotic treatmentup to 14 days (duration of hospital stay)

(y/n)

Amount of CSF drained by lumbar drainup to 14 days (duration of hospital stay)

in ml

Mortalityup to 14 days (duration of hospital stay) and 6 month

cerebral cause of death (y/n)

Trial Locations

Locations (3)

LMU München

🇩🇪

München, Bayern, Germany

Department of Neurology, University Hospital Heidelberg

🇩🇪

Heidelberg, Baden-Württemberg, Germany

Charite Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath